Mass. Biotech Biz Gets PTAB To Wipe Alzheimer's Drug Patent
A panel of Patent Trial and Appeal Board judges has sided with arguments from Boston biotech developer Alzheon Inc. that the patent office never should have granted a patent to a smaller...To view the full article, register now.
Already a subscriber? Click here to view full article